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Knowing whether an individual operator’s annual volume of
percutaneous transluminal coronary angioplasty (PTCA) pro-
cedures affects the risk of acute complications has major
implications for all involved in today’s health care system:
Noninterventionalist physicians, who refer patients for inter-
ventions, want to choose operators who will successfully per-
form the procedure without complications. Health care payers
want to contract with selected, high quality operators. Patients
undergoing an interventional procedure, who have the greatest
at stake, may know nothing more about their interventional
cardiologist than how many procedures he or she performs
each year.
All of these issues are magnified by the fact that a large
proportion of angioplasty laboratories and operators in the
United States are considered “low volume” (1–5). As such, the
effects of operator volume on PTCA outcomes has become an
important, and controversial, subject, and the cardiology com-
munity must struggle with the consequences of interpretations
and misinterpretations of the operator volume–complication
relation.
Obstacles to assessing a volume–complication relation and
an operator’s risk. An accurate assessment of the effects of
operator volume on complication risk is fraught with numerous
obstacles (6):
1. Because acute complications from coronary interventions
are rare, large numbers of patients are required to identify
small, but clinically meaningful, differences in outcomes be-
tween lower and higher volume operators. Measuring out-
comes in the individual operator is even more problematic; the
operators whom one wants to know most about, the lowest
volume operators, provide the least amount of data. This
creates the “low volume operator paradox”: The ability to
identify operators whose outcomes are statistically significantly
worse than expected is inversely related to the number of
procedures they perform (7). The analogy to baseball statistics
is very informative (8): Just because a batter has one hit in his
first three at bats of the season does not in any way mean that
he is a .333 hitter.
2. As technology advances and experience increases, the
benchmark risk of acute complications from percutaneous
revascularization procedures continues to decline (9,10). As a
result, comparisons of current outcomes with outcomes from
older studies are problematic, even if “older” means just
several years ago. In addition, the use of different definitions
and methods to measure outcomes limits the ability to make
comparisons between studies (11). Newer technology, such as
stents, may also affect the association between experience and
outcomes.
3. When comparing complication rates between operators
or measuring risk in an individual operator, it is important to
adjust for case mix. For example, compared with lower volume
operators, higher volume operators may take on more compli-
cated, higher risk patients (12) who may stand the most to gain
from revascularization (13,14).
4. Measuring outcomes and predictors of outcomes can be
a matter of subjectivity or, worse, “manipulation” (7). In
addition, which operators have results that are considered
worse than expected may depend on the outcome measured
(7).
5. Although acute complications are important and appro-
priate outcomes to measure, they do not reflect long-term
results of interventional procedures. Thus, they may not pro-
vide a complete assessment of quality.
Running into obstacles. Klein et al., (15) in their report in
this issue of the Journal, present important information from a
quality-controlled database about complications among rela-
tively low volume operators in their moderate volume labora-
tory. By wisely including several years’ worth of data, they are
able to show that their operators can achieve excellent results,
comparable to those in the published reports. However, as they
acknowledge, they run head-on into several of the obstacles
just discussed, making it difficult to identify a relation between
volume and complications.
The small number of patients and the narrow range of
operator volumes in their study prevent them from being able
to determine whether there is an operator volume–complication
relation. The comparison with other registries is limited by the
lack of direct adjustment for each patient’s clinical character-
istics; the use of two registries that represent angioplasty
experience from 5 to 7 years before their study; the differences
in inclusion criteria and methods of measuring outcomes
among the studies; and the lack of information about the
operator volumes in these previous studies. Finally, the study
represents one moderate volume laboratory, thus limiting
generalizability and preventing an assessment of the interac-
tion between operator volume and laboratory volume.
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In contrast to the results of the present study, the accumu-
lating evidence from large, adequately powered studies sug-
gests that, on average, higher volume operators are more likely
to have fewer complications than lower volume operators
(4,5,16,17). This finding is not unexpected given the extremely
consistent finding of an institutional volume–complication re-
lation among several studies (1,4,18,19) and given that individ-
ual operators constitute an important component of each
institution.
Despite all these caveats, the report by Klein et al. (15) does
illustrate an important fact that should not be lost in all the
statistical averages: Even if there is an association between
operator volume and complications, there will be certain
laboratories with low volume operators who can perform
PTCA with a low risk of complications. The question now is,
What do we do about low volume operators?
Operator volume as a risk factor. One approach that may
put operator volume in perspective is to view “operator
volume” like any other risk factor for PTCA complications. A
patient with a risk factor is, on average and all else being equal,
at higher risk of a complication than a patient without that risk
factor. However, a single risk factor is only one element that
characterizes a patient’s overall risk and must be considered in
the context of the patient’s other risk factors. Nonetheless, in
such a patient, more careful consideration must be given to the
feasibility and appropriateness of performing PTCA.
It is the same for “operator volume.” It appears to be a
characteristic of a physician that increases the chance of a
PTCA-related complication. Just as for a patient-specific risk
factor, this does not mean that a low volume operator cannot
have success rates similar to a high volume operator; only that,
on average and all else being equal, a low volume operator has
a higher risk for acute complications. Because yearly operator
volume is but one component of the complement of technical
and judgment skills and experience that an operator brings to
each procedure, it should not be viewed as the sole determi-
nant of competence. Nonetheless, like the patient-specific risk
factor, the “low volume risk factor” must also be taken into
account when determining the appropriateness of performing
PTCA and the likelihood of success.
Some possible approaches to the risk factor of low operator
volume. One potential approach to the low volume operator is
to try to determine whether a given low volume operator truly
does bring a risk factor to the patient. To try to overcome the
“low-volume operator paradox,” one can increase the numbers
by examining an operator’s experience over multiple years.
However, because risk adjustment may be unreliable, because
low volume operators will still provide low numbers of proce-
dures even over several years (6), and because changing
therapies and expected outcomes in interventional cardiology
may make it inappropriate to lump together several years’
experience, there remains uncertainty in this approach. A
second approach, therefore, is to simply remove the risk factor;
that is, set minimal volume limits for operators as a way to try
to maximize the overall quality of care of patients (20).
Whether this approach will affect practice is unclear given the
substantial number of low volume laboratories and operators
who continue to practice (1–5) despite previous guidelines.
Also, where to set the minimal cutoff is subject to debate, and
how to incorporate the effects of overall institutional volume
and previous operator experience is currently unclear. Of
course, setting minimal volume limits should not “inspire”
interventionalists to expand their practice unnecessarily simply
to increase their volume. A third approach is to intervene to try
to reduce the increased risk imposed by the low volume
operator. For example, consideration should be given to
referral of high risk patients to high volume operators (al-
though recent data [16] suggest that this practice may not be
effective), concentration of use of new devices among only
experienced interventionalists, mentorship of low volume op-
erators and, if necessary, suspension of privileges of any
operator with poor outcomes. Operators with worse than
predicted adjusted outcomes should undergo a careful review
that measures the characteristics of their patient population,
their process of delivering care and the support available to
them from colleagues and support personnel. This review is
particularly important for low volume operators, especially
those whose results do not clearly fall within acceptable norms.
It is also important that this “peer-review” (8) be done before
irreversible action is taken against an operator. A fourth
approach that has been suggested is formal disclosure to
patients of both the data concerning the volume–complication
relation and the volume of procedures that their physician
performs (21).
Which one or combination of these approaches to chose is
not an easy question. What we really need is to continue to
refine our ability to measure, monitor and improve outcomes.
Efforts should continue to 1) develop and validate better risk
adjustment methods; 2) use properly developed, large obser-
vational studies to assess the interplay between operator and
institutional volume and the effects of both previous experi-
ence (22) and supervision of low volume operators by more
experienced operators (as in the laboratory described in the
study by Klein et al. (15)); 3) constantly update the acceptable
risk of outcomes through the use of contemporary, broad-
based databases; 4) ensure that laboratories collect accurate
and uniform measures of outcomes and predictors of outcomes
among all patients undergoing interventional procedures
(6,23); and 5) try to better understand what it takes to make a
high quality laboratory such as that described in the study by
Klein et al. (15).
Who should take on all these responsibilities? We believe
the cardiology community should continue to take the lead.
Outcome assessment, risk adjustment and public disclosure of
operator and laboratory results are already occurring in some
areas and are likely to expand (3). We must make sure that
these processes improve and are properly interpreted and that
patients are not denied access to care solely because physicians
are afraid of being penalized for performing PTCA in high risk
patients when appropriate.
Efforts to measure and improve quality are in the best
interest of our patients. We in the cardiology community must
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address these issues ourselves if we are to ensure the quality of
patient care.
We thank John W. Hirshfeld, Jr., MD, FACC for helpful comments.
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